FDA issued a Warning Letter to Park Infusioncare LP dba Preferred Homecare on 3/1/2018 as a result of this inspection.
483 Park Infusioncare LP dba Preferred Homecare Jul 2017

483 Park Infusioncare LP dba Preferred Homecare Jul 2017

Anh Lac FDA$119.00 - Available Now

FDA investigators audited the Park Infusioncare LP dba Preferred Homecare - Dallas, TX, United States facility and issued 4 inspectional observations (via FDA 483) on 11 Jul 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 4
  • Inspection end: 11 Jul 2017
  • Location: Dallas, United States
  • FEI: 3013330273
Add To Cart
Park Infusioncare LP dba Preferred Homecare FDA inspection 483 Jul 2017Add To Cart